berberine has been researched along with vancomycin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Herdewijn, P; Maiti, M; Nauwelaerts, K | 1 |
| Do, TH; Huynh, TN; Ngo, TD; Thai, KM; Tran, CD; Tran, NC; Tran, TD | 1 |
| Kaul, M; Kelley, C; LaVoie, EJ; Lu, S; Parhi, A; Pilch, DS | 1 |
| Kaul, M; Kelley, C; LaVoie, EJ; Parhi, A; Pilch, DS; Zhang, Y | 1 |
| Chen, H; Liu, T; Tang, J; Wang, J; Xu, YN; Xue, W; Yang, CG; Yang, F; Yang, T; Yi, Z; Yu, LF | 1 |
| Chan, KF; Chan, TH; Fang, Z; Guo, Q; Leung, YC; Lu, Y; Lui, HK; Sun, N; Wong, KY; Wu, W; Yuan, W; Zheng, S | 1 |
| Chen, W; Ma, S; Song, D; Zhang, N; Zhang, P; Zhang, S | 1 |
| Liu, W; Lv, Z; Peng, G; Su, J; Xu, H | 1 |
| Piotrowski, M; Pituch, H; Wultańska, D | 1 |
9 other study(ies) available for berberine and vancomycin
| Article | Year |
|---|---|
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
Topics: Aminoglycosides; Antineoplastic Agents; Base Sequence; DEAD-box RNA Helicases; Humans; MicroRNAs; Models, Biological; Molecular Sequence Data; Ribonuclease III; RNA Processing, Post-Transcriptional | 2012 |
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2012 |
Antibacterial activity of substituted dibenzo[a,g]quinolizin-7-ium derivatives.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Berberine; Cytoskeletal Proteins; Enterococcus faecalis; Microbial Sensitivity Tests; Quinolizines; Staphylococcus aureus; Structure-Activity Relationship | 2012 |
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Enterococcus faecalis; HEK293 Cells; Humans; Isoquinolines; Molecular Targeted Therapy; Staphylococcus aureus | 2012 |
The synthesis and antistaphylococcal activity of 9, 13-disubstituted berberine derivatives.
Topics: Anti-Bacterial Agents; Berberine; Cell Line; Chemistry Techniques, Synthetic; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests | 2017 |
Design, synthesis and antibacterial evaluation of 2,4-disubstituted-6-thiophenyl-pyrimidines.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Thiophenes; Vancomycin-Resistant Enterococci | 2019 |
Modification of 5-methylphenanthridium from benzothiazoles to indoles as potent FtsZ inhibitors: Broadening the antibacterial spectrum toward vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzothiazoles; Cytoskeletal Proteins; Humans; Indoles; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clostridioides difficile; Colitis; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Random Allocation; Recurrence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Weight Loss | 2015 |
The effect of berberine chloride and/or its combination with vancomycin on the growth, biofilm formation, and motility of Clostridioides difficile.
Topics: Anti-Bacterial Agents; Berberine; Biofilms; Chlorides; Clostridioides difficile; Clostridium Infections; Drug Synergism; Humans; Locomotion; Microbial Sensitivity Tests; Microbial Viability; Vancomycin | 2020 |